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the cartilage. The purpose of the current study was to determine
the effect of IL-1 on global gene expression in chondrocytes from
individuals with no history of OA and chondrocytes from cartilage
with patients with OA.
Methods: Chondrocytes were isolated from cartilage of a donor
greater than 60 years without history of OA, intact cartilage from
total joint arthroplasty (OA) and a young adult without OA, and
cultured at 106 cells/cm2. IL-1 was added at concentrations of
2 ng/ml for some experiments and 0.1, 1 and 10 ng/ml for other
experiments. In some cultures IL-1 was removed at 24 hrs and
the anabolic factors BMP-2 and TGF-beta1 were added and
cultured for an additional 24 hrs. RNA was isolated by the Trizol
method and cDNA was prepared for microarray analysis using
cDNA arrays of 20,000 human gene transcripts. Microarray data
was verified using semi-quantitative RT-PCR.
Results: Microarray analysis suggested that a large set of
chemokine genes were the most highly responsive to IL-1 stim-
ulating begin increased 25-75 fold by 2 ng/ml (see Table 1). A
second set of chemokines was increased 3-11 fold. The increase
was observed down to a level of 100 pg/ml IL-1. As expected
type II collagen gene expression decreased by 50% and MMP-
13 expression increased 6 fold. Surprisingly, expression of the
aggrecanase, ADAMS-TS5, was present in all cartilages exam-
ined and down-regulated in normal cartilage by 7 fold and in
OA cartilage approximately 5 fold. All results were confirmed by
RT-PCR. BMP-2 was increased by 4 fold. IL-1 autoregulated its
own gene by 20 fold.
Table 1. Gene Expression (fold increase or decrease)
Gene Fold Increase or Decrease
Group 1:
CXCL2 (Gro-b)
CXCL8 (IL-8)
CXCL1 (Gro-1)
CCL4 (MIP-b)
CCL20 (MIP-3a) 25-75
CCL3L1 (LD78b)
CSCL6 (GCP-2)
IL-6CCL3 (MIP-1a)
CCL5 (RANTES)
CSCL5 (ENA-78)
CS3CL5 (Fractalkine) 3-11
CCL2 (MCP-1)
CCL8 (MCP-2)
MMP13 6
BMP-2 4
COL2A1 0.4
ADAMS-TS5 0.13
When the concentration of IL-1 was reduced to 100 pg/ml, the
chemokines were increased while the other effects of IL-1 were
reduced. The same result was observed in all ages of normal
cartilage. For the OA cartilage, gene expression was similar as
the low concentrations of IL-1, however, with addition of IL-1, the
effects were more dramatic. Interestingly, only TGF-BETA could
reverse some, but not all effects.
Conclusions: Two distinct sets of chemokines were the most
highly responsive of all cartilage genes to culture with IL-1. The
effects of IL-1 on other genes vary with the concentration of
the cytokine, but the chemokines are the most responsive. This
indicates that at these genes are differentially regulated. Sur-
prisingly, the aggrecanase gene ADAMS-TS5 was present in all
chondrocytes and down-regulated by IL-1. While the expected
effects of IL-1 were observed, other previously unknown effects
were observed. In addition, these experiments clearly demon-
strate that reactions vary by concentration. Thus even more
complex effects of inflammation on cartilage are revealed.
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Purpose: Calcitonin has been suggested to have chondropro-
tective effects in joint degenerative diseases. In vitro studies have
demonstrated that one signalling pathway of calcitonin is via the
second messenger cAMP. We investigated whether increased
cAMP levels in chondrocytes would be chondroprotective in a
model of cartilage degradation.
Methods: Cartilage degradation was induced in bovine articular
cartilage explants cultures by stimulation with 10 ng/mL onco-
statin M (OSM) and 20 ng/mL TNF. cAMP levels was stimulated
by treatment with either forskolin (cAMP activator, 1-64 μM) or
IBMX (phosphodiesterase inhibitor, 1-64 μM), and the intracellu-
lar cAMP levels were evaluated by ELISA. Cartilage degradation
was evaluated in the conditioned medium by quantification of
crosslinked C-telopeptide fragments of type II collagen (CTX-II),
matrix metalloproteinase (MMP) mediated aggrecan turnover by
a novel ELISA detecting the 342FFGVG-G2 cleavage site, ag-
grecanase mediated aggrecan turnover by a novel ARGS-G2
ELISA. Biochemical findings were validated by immunohisto-
chemistry of CTX-II fragments and toluidine blue stainings of
proteoglycans. Changes in MMP expression and activity in the
conditioned medium were assessed by gelatine zymography.
Alamarblue was used to evaluate cyto-toxicity after stimulation
with the various compounds and cytokines.
Results: OSM and TNF treatment induced a 500-fold increase
in CTX-II release to the supernatant (P<0.001) compared to
vehicle control. Both forskolin and IBMX dose-dependently in-
hibited CTX-II release (P<0.001), which at the highest concen-
tration was completely abrogated. OSM and TNF induced 8
fold increase in MMP mediated aggrecan degradation (FFGV-
G2), which was dose-dependently inhibited by both forskolin
and IBMX to 75%, (P<0.001). OSM and TNF evoked marked
increases in MMP expression, which was dose-dependently in-
hibited by both forskolin and IBMX. With regards to aggrecanase
activity, OSM and TNF induced a 4 fold increase in ARGS-
G2 degradation products of aggrecan. Forskolin significantly in-
hibited aggrecanase mediated aggrecan degradation by 60%
(P<0.01), whereas IBMX inhibited aggrecanase activity by 40%
albeit non-significant. None of the compounds affected cell num-
ber or viability.
Conclusions: cAMP levels in chondrocytes play a key role in
controlling the catabolic activity. Increased cAMP levels in chon-
drocytes results in inhibition of aggrecanase as well as MMP
expression and activity, and consequently a strong inhibition
of cartilage degradation. Specific cAMP modulators in chon-
drocytes, such as calcitonin, may be potential treatments for
cartilage degenerative diseases.
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Purpose: To investigate the effects of estrogen compared to
